Kelso Pharma secures £140m of acquisition funding and appoints senior pharma executive as Non-Executive Director
Kelso Pharma, the growing specialty pharma business backed by Apposite Capital, the healthcare specialist private equity investor, announces that it has secured over £140 million of acquisition funding and appointed former ADVANZ PHARMA CEO, Graeme Duncan, as Non-Executive Director. A proportion of the funding was used by Kelso Pharma in its acquisition of ALTURiX last […]
